PharmaResearch KRX:214450KOSDAQ

파마리서치 · Korean news coverage and regulatory filings, organized.

Articles, 24h2
Articles, 7 days17
DART filings, 7 days1
Articles tracked210since Sep 11

In Q2 2026, PharmaResearch reported revenue of ₩179bn, up 27.1% year on year, and operating profit of ₩66.5bn. PharmaResearch (파마리서치) appeared in 17 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 20 with 15 articles. It was most often mentioned alongside HYBE, Classys and WonIk.

Filing signals Revenue & profit growth Op. margin 20%+ Dividend grower Major holder adding Screener

PharmaResearch quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩179bn+27.1%₩66.5bn
margin 37.2%
₩56.2bn
Q1 2026₩146bn+25.0%₩57.3bn
margin 39.2%
₩48.7bn
Q4 2025 derived₩143bn+39.1%₩51.9bn
margin 36.2%
₩39.3bn
Q3 2025₩135bn+51.8%₩61.9bn
margin 45.7%
₩50.9bn
Q2 2025₩141bn+69.2%₩55.9bn
margin 39.7%
₩42.0bn
Q1 2025₩117bn+56.5%₩44.7bn
margin 38.3%
₩36.0bn
Q4 2024 derived₩103bn+47.3%₩33.7bn
margin 32.7%
₩16.4bn
Q3 2024₩89.2bn+29.7%₩34.9bn
margin 39.1%
₩25.5bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

PharmaResearch top stories 2 weeks, by number of outlets

  1. 1
    파마리서치, 에스테틱 라인업 학술 마케팅 강화
    7 outlets · 7 articlesFirst report Oct 22 08:36 핀포인트뉴스
  2. 2
    파마리서치 리쥬란코스메틱, 美 코스트코 25곳 입점
    5 outlets · 5 articlesFirst report Oct 23 08:44 메디파나뉴스
  3. 3
  4. 4
    파마리서치, 대한미용의사회 '스마트아카데미' 참가
    3 outlets · 3 articlesFirst report Oct 20 09:20 핀포인트뉴스
  5. 5
    파마리서치, 대한미용의사회서 필러 ‘리쥬비엘’ 시술법 공유
    2 outlets · 2 articlesFirst report Oct 20 08:40 한국경제
  6. 6
    파마리서치, 리쥬란·에버클 학술 마케팅 확대
    2 outlets · 2 articlesFirst report Oct 22 09:38 메디파나뉴스

Latest PharmaResearch news Korean headlines